Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
- Conditions
- Vaccination
- Interventions
- Other: educational text message remindersOther: conventional text message reminders
- Registration Number
- NCT02231957
- Lead Sponsor
- Columbia University
- Brief Summary
There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 416
Parent with
- adolescent aged 11-17 years;
- adolescent with ≥1 chronic medical condition;
- adolescent with clinic visit in last 12 months;
- cell phone number listed in hospital registration system
Parent who:
- does not speak English or Spanish;
- is unwilling to receive text message vaccine reminders;
- anticipates moving from area in coming 12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description educational text message reminders educational text message reminders receipt of education-embedded text message vaccine reminders conventional text message reminders conventional text message reminders receipt of conventional text message vaccine reminders
- Primary Outcome Measures
Name Time Method Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s) 12 weeks after intervention start
- Secondary Outcome Measures
Name Time Method Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination 24 weeks after intervention start Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s) 24 weeks after intervention start
Trial Locations
- Locations (1)
NewYork-Presbyterian Hospital/Columbia University Medical Center
🇺🇸New York, New York, United States